stella
beta
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment — Stella
Recruiting
Back to Tumor, Solid trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(2 sites)
United States
South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas
START Mountain Region, West Valley City, Utah
View full record on ClinicalTrials.gov